Williams, J., Munro, K. and Palmer, T. (2014) Role of ubiquitylation in controlling suppressor of cytokine signalling 3 (SOCS3) function and expression. Cells, 3(2), pp. 546-562. (doi: 10.3390/cells3020546) (PMID:24886706) (PMCID:PMC4092859)
|
Text
169408.pdf - Published Version Available under License Creative Commons Attribution. 450kB |
Abstract
The realisation that unregulated activation of the Janus kinase–signal transducer and activator of transcription (JAK–STAT) pathway is a key driver of a wide range of diseases has identified its components as targets for therapeutic intervention by small molecule inhibitors and biologicals. In this review, we discuss JAK-STAT signalling pathway inhibition by the inducible inhibitor “suppressor of cytokine signaling 3 (SOCS3), its role in diseases such as myeloproliferative disorders, and its function as part of a multi-subunit E3 ubiquitin ligase complex. In addition, we highlight potential applications of these insights into SOCS3-based therapeutic strategies for management of conditions such as vascular re-stenosis associated with acute vascular injury, where there is strong evidence that multiple processes involved in disease progression could be attenuated by localized potentiation of SOCS3 expression levels.
Item Type: | Articles |
---|---|
Status: | Published |
Refereed: | Yes |
Glasgow Author(s) Enlighten ID: | Palmer, Dr Timothy and MUNRO, KIRSTEN and Williams, Dr Jamie |
Authors: | Williams, J., Munro, K., and Palmer, T. |
College/School: | College of Medical Veterinary and Life Sciences > School of Cardiovascular & Metabolic Health College of Medical Veterinary and Life Sciences > School of Molecular Biosciences |
Journal Name: | Cells |
Publisher: | MDPI |
ISSN: | 2073-4409 |
ISSN (Online): | 2073-4409 |
Copyright Holders: | Copyright © 2014 The Authors |
First Published: | First published in Cells 3(2):546-562 |
Publisher Policy: | Reproduced under a Creative Commons License |
University Staff: Request a correction | Enlighten Editors: Update this record